Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Northwest Biotherapeutics Expands Senior Management Team | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Northwest Biotherapeutics Expands Senior Management Team

Duffy joins the company from Merck, where he served as Research Scientific Director in the Keytruda program

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Northwest Biotherapeutics has expanded its senior management team with the addition of Dr. Kevin T. Duffy as vice president, Medical Affairs and External Collaborations.

Dr. Duffy joins the company from Merck, where he served as Research Scientific Director in the Keytruda program during the last five years.  Dr. Duffy’s roles included scientific support and outreach to health care providers and national and regional scientific leaders in over 20 different solid tumors and hematologic malignancies (blood cancers and lymphomas) relating to Merck’s clinical development and commercialization of Keytruda, as well as ongoing scientific support for Merck’s Investigator-Initiated Study Program. He served as the national contact point between the scientific affairs team in the field and the internal R&D team in Merck for studies in first-line non-small cell lung cancer, triple negative breast cancer and ER+/HER2- breast cancer, and metastatic prostate cancer.  

Prior to Merck, Dr. Duffy served in Medical Affairs and Scientific Affairs positions in several pharmaceutical companies, including as a Regional Scientific Manager for oncology and cardiovascular therapeutics at AstraZeneca.  Dr. Duffy has a Ph.D. in molecular pharmacology and structural biology, with a focus on oncology, as well as an MBA.  

Linda Powers, chief executive officer of NW Bio, said, “Dr. Duffy’s experience with immune therapies for cancer and one of the most successful product development programs in the field will be an invaluable addition to our team.  We at NW Bio could not be more excited about Dr. Duffy’s choice to join us and help realize the broad potential of DCVax.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters